Current landscape and challenges of neuro-oncological molecular tumor boards in Germany: results of a nationwide follow-up survey - Poll - MDSpire

Current landscape and challenges of neuro-oncological molecular tumor boards in Germany: results of a nationwide follow-up survey

  • By

  • Lisa S. Hönikl

  • Sebastian Lange

  • Bernhard Meyer

  • Stephanie E. Combs

  • Alisa M. Lörsch

  • Anna Lena Illert

  • Arthur Wagner

  • Friederike Schmidt-Graf

  • March 31, 2026

  • 0 min

Share

Original Source(s)

Current landscape and challenges of neuro-oncological molecular tumor boards in Germany: results of a nationwide follow-up survey

  • by Lisa S. Hönikl, Sebastian Lange, Bernhard Meyer, Stephanie E. Combs, Alisa M. Lörsch, Anna Lena Illert, Arthur Wagner, Friederike Schmidt-Graf

  • March 31, 2026

Related Content

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy